Thrombin Generation and Platelet Activation in CRS/HIPEC

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Mesothelioma; PeritoneumPseudomyxoma PeritoneiPeritoneal Carcinomatosis
Interventions
PROCEDURE

CRS/HIPEC

The generic surgical approach involved peritonectomy procedures and visceral resections called CRS as described by Sugarbaker (1995). Peritoneal disease burden was assessed using the perito- neal cancer index (PCI), which scores 13 intra-abdominal sites on a scale of 0 (no disease) to 3 (lesion size \> 5 cm), thus giving a range of possible scores from 0 to 39. The same team performed the surgical procedure of all included patients. Before connection to the patient, the circuit was filled with dextrose 5% (2 L/m2 body surface area) and warmed to 37°C.

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER

NCT03034850 - Thrombin Generation and Platelet Activation in CRS/HIPEC | Biotech Hunter | Biotech Hunter